---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-010533"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2024-08-01T23:59:59+00:00"
generated_at: "2026-05-31T13:42:14.083506+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# IRADIMED reports record Q2 revenue $17.9M, GAAP EPS $0.38

## Summary
- Revenue of $17.9M, up 11.2% YoY; operating income $5.6M, up 13.4%.
- GAAP diluted EPS $0.38; non-GAAP diluted EPS $0.42 vs $0.36 in Q2 2023.
- Q3 2024 guidance: revenue $18.0-18.2M, GAAP EPS $0.34-0.37.
- FY 2024 reaffirmed: revenue $72-74M, GAAP EPS $1.37-1.47.
- Declares quarterly dividend $0.15/share payable Aug 30, record Aug 20.

## SEC filing metadata
- accession: 0001558370-24-010533
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2024-08-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837024010533/0001558370-24-010533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837024010533/irmd-20240801x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-010533
- JSON: https://secwatch.observer/filing/0001558370-24-010533.json
- Plain text: https://secwatch.observer/filing/0001558370-24-010533.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.